The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies-Reference-Cited by-同舟云学术

The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies

Published:2017-10-02 Issue:10 Volume:9 Page:309
ISSN:2072-6651
Container-title:Toxins
language:en
Short-container-title:Toxins

Author:

Rasetti-Escargueil Christine,Avril Arnaud,Miethe Sebastian,Mazuet Christelle,Derman Yagmur,Selby Katja,Thullier Philippe,Pelat Thibaut,Urbain Remi,Fontayne Alexandre,Korkeala Hannu,Sesardic Dorothea,Hust Michael^ORCID,Popoff Michel

Publisher

MDPI AG

Subject

Health, Toxicology and Mutagenesis,Toxicology

Link

http://www.mdpi.com/2072-6651/9/10/309/pdf

Reference90 articles.

1. Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity

2. High-Affinity, Human Antibody-Like Antibody Fragment (Single-Chain Variable Fragment) Neutralizing the Lethal Factor (LF) of Bacillus anthracis by Inhibiting Protective Antigen-LF Complex Formation

3. Selection of a Macaque Fab with Framework Regions Like Those in Humans, High Affinity, and Ability To Neutralize the Protective Antigen (PA) of Bacillus anthracis by Binding to the Segment of PA between Residues 686 and 694

4. Isolation and Characterisation of a Human-Like Antibody Fragment (scFv) That Inactivates VEEV In Vitro and In Vivo

5. Human-like antibodies neutralizing Western equine encephalitis virus

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Isolation and characterization of Hc-targeting chimeric heavy chain antibodies neutralizing botulinum neurotoxin type B;Frontiers in Immunology;2024-04-30

2. Development and characterization of a novel neutralizing scFv vectored immunoprophylaxis against botulinum toxin type A;Journal of Drug Targeting;2024-01-10

3. Humanized Antibodies. Modern Developments and Prospects for the Creation of Medical Protectors Against Biological Threads and Hazards;Journal of NBC Protection Corps;2024-01-08

4. Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs;Applied Microbiology and Biotechnology;2023-04-14

5. Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A;Frontiers in Immunology;2023-02-14